<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37209261</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7241</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cardiovascular drugs and therapy</Title><ISOAbbreviation>Cardiovasc Drugs Ther</ISOAbbreviation></Journal><ArticleTitle>Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review.</ArticleTitle><Pagination><StartPage>1017</StartPage><EndPage>1032</EndPage><MedlinePgn>1017-1032</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10557-023-07465-w</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">The risk of cardiovascular complications due to SARS-CoV-2 are significantly increased within the first 6 months of the infection. Patients with COVID-19 have an increased risk of death, and there is evidence that many may experience a wide range of post-acute cardiovascular complications. Our work aims to provide an update on current clinical aspects of diagnosis and treatment of cardiovascular manifestations during acute and long-term COVID-19.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">SARS-CoV-2 has been shown to be associated with increased incidence of cardiovascular complications such as myocardial injury, heart failure, and dysrhythmias, as well as coagulation abnormalities not only during the acute phase but also beyond the first 30 days of the infection, associated with high mortality and poor outcomes. Cardiovascular complications during long-COVID-19 were found regardless of comorbidities such as age, hypertension, and diabetes; nevertheless, these populations remain at high risk for the worst outcomes during post-acute COVID-19. Emphasis should be given to the management of these patients. Treatment with low-dose oral propranolol, a beta blocker, for heart rate management may be considered, since it was found to significantly attenuate tachycardia and improve symptoms in postural tachycardia syndrome, while for patients on ACE inhibitors or angiotensin-receptor blockers (ARBs), under no circumstances should these medications be withdrawn. In addition, in patients at high risk after hospitalization due to COVID-19, thromboprophylaxis with rivaroxaban 10 mg/day for 35 days improved clinical outcomes compared with no extended thromboprophylaxis. In this work we provide a comprehensive review on acute and post-acute COVID-19 cardiovascular complications, symptomatology, and pathophysiology mechanisms. We also discuss therapeutic strategies for these patients during acute and long-term care and highlight populations at risk. Our findings suggest that older patients with risk factors such as hypertension, diabetes, and medical history of vascular disease have worse outcomes during acute SARS-CoV-2 infection and are more likely to develop cardiovascular complications during long-COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kole</LastName><ForeName>Christo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4695-3723</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Sismanoglio General Hospital of Attica, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece. christo.kole@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Stefanou</LastName><ForeName>&#x395;leni</ForeName><Initials>&#x395;</Initials><AffiliationInfo><Affiliation>Artificial Kidney Unit, General Hospital of Messinia, Kalamata, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karvelas</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1452-1192</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schizas</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7046-0112</Identifier><AffiliationInfo><Affiliation>First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toutouzas</LastName><ForeName>Konstantinos P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>National and Kapodistrian University of Athens, Ippokration General Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cardiovasc Drugs Ther</MedlineTA><NlmUniqueID>8712220</NlmUniqueID><ISSNLinking>0920-3206</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dysrhythmias</Keyword><Keyword MajorTopicYN="N">Acute-COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiovascular manifestations</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Myocardial injury</Keyword><Keyword MajorTopicYN="N">Post-COVID-19</Keyword></KeywordList><CoiStatement>Christo Kole declares that he has no conflict of interest. &#x395;leni Stefanou declares that she has no conflict of interest. Nikolaos Karvelas declares that he has no conflict of interest. Dimitrios Schizas declares that he has no conflict of interest. Konstantinos P. Toutouzas declares that he has no conflict of interest. The authors have no competing interests to declare that are relevant to the content of this article. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. The authors have no financial or proprietary interests in any material discussed in this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>20</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>20</Day><Hour>14</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37209261</ArticleId><ArticleId IdType="pmc">PMC10199303</ArticleId><ArticleId IdType="doi">10.1007/s10557-023-07465-w</ArticleId><ArticleId IdType="pii">10.1007/s10557-023-07465-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270&#x2013;273. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265&#x2013;269. doi: 10.1038/s41586-020-2008-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization WH. WHO Coronavirus (COVID-19) Dashboard. 2023. https://covid19.who.int/. Accessed 2 Feb 2023.</Citation></Reference><Reference><Citation>Henry BM, Lippi G. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports. J Crit Care. 2020;58:27&#x2013;28. doi: 10.1016/j.jcrc.2020.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2020.03.011</ArticleId><ArticleId IdType="pmc">PMC7118619</ArticleId><ArticleId IdType="pubmed">32279018</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay MZ, Poh CM, Renia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363&#x2013;374. doi: 10.1038/s41577-020-0311-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(23):2950&#x2013;2973. doi: 10.1016/j.jacc.2020.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.04.031</ArticleId><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendren NS, Drazner MH, Bozkurt B, Cooper LT., Jr Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. 2020;141(23):1903&#x2013;1914. doi: 10.1161/CIRCULATIONAHA.120.047349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047349</ArticleId><ArticleId IdType="pmc">PMC7314493</ArticleId><ArticleId IdType="pubmed">32297796</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. doi: 10.1136/bmj.m1966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1966</ArticleId><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhakal BP, Sweitzer NK, Indik JH, Acharya D, William P. SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart. Heart Lung Circ. 2020;29(7):973&#x2013;987. doi: 10.1016/j.hlc.2020.05.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2020.05.101</ArticleId><ArticleId IdType="pmc">PMC7274628</ArticleId><ArticleId IdType="pubmed">32601020</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052&#x2013;2059. doi: 10.1001/jama.2020.6775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli A, Pezzati L, Conti F, et al. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020;71(15):889&#x2013;890. doi: 10.1093/cid/ciaa330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa330</ArticleId><ArticleId IdType="pmc">PMC7184514</ArticleId><ArticleId IdType="pubmed">32215618</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Xie X, Tu Z, et al. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct Target Ther. 2021;6(1):255. doi: 10.1038/s41392-021-00679-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00679-0</ArticleId><ArticleId IdType="pmc">PMC8261820</ArticleId><ArticleId IdType="pubmed">34234112</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl) 2020;133(9):1025&#x2013;1031. doi: 10.1097/CM9.0000000000000744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000744</ArticleId><ArticleId IdType="pmc">PMC7147277</ArticleId><ArticleId IdType="pubmed">32044814</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507&#x2013;513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Task Force for the management of C-otESoC. Baigent C, Windecker S, et al. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. Cardiovasc Res. 2022;118(6):1385&#x2013;1412. doi: 10.1093/cvr/cvab342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab342</ArticleId><ArticleId IdType="pmc">PMC8690255</ArticleId><ArticleId IdType="pubmed">34864874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranard LS, Fried JA, Abdalla M, et al. Approach to Acute Cardiovascular Complications in COVID-19 Infection. Circ Heart Fail. 2020;13(7):e007220. doi: 10.1161/CIRCHEARTFAILURE.120.007220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.120.007220</ArticleId><ArticleId IdType="pmc">PMC8126417</ArticleId><ArticleId IdType="pubmed">32500721</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Cai Y, et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J. 2020;41(22):2070&#x2013;2079. doi: 10.1093/eurheartj/ehaa408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa408</ArticleId><ArticleId IdType="pmc">PMC7239100</ArticleId><ArticleId IdType="pubmed">32391877</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangalore S, Sharma A, Slotwiner A, et al. ST-Segment Elevation in Patients with Covid-19 - A Case Series. N Engl J Med. 2020;382(25):2478&#x2013;2480. doi: 10.1056/NEJMc2009020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009020</ArticleId><ArticleId IdType="pmc">PMC7182015</ArticleId><ArticleId IdType="pubmed">32302081</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y, Lichter Y, Taieb P, et al. Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study. Circulation. 2020;142(4):342&#x2013;353. doi: 10.1161/CIRCULATIONAHA.120.047971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047971</ArticleId><ArticleId IdType="pmc">PMC7382541</ArticleId><ArticleId IdType="pubmed">32469253</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844&#x2013;847. doi: 10.1111/jth.14768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante G, Fazzari F, Cozzi O, et al. Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomography. Cardiovasc Res. 2020;116(14):2239&#x2013;2246. doi: 10.1093/cvr/cvaa193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa193</ArticleId><ArticleId IdType="pmc">PMC7454387</ArticleId><ArticleId IdType="pubmed">32637999</ArticleId></ArticleIdList></Reference><Reference><Citation>Schott JP, Mertens AN, Bloomingdale R, et al. Transthoracic echocardiographic findings in patients admitted with SARS-CoV-2 infection. Echocardiography. 2020;37(10):1551&#x2013;1556. doi: 10.1111/echo.14835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/echo.14835</ArticleId><ArticleId IdType="pmc">PMC7537524</ArticleId><ArticleId IdType="pubmed">32949015</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5(7):811&#x2013;818. doi: 10.1001/jamacardio.2020.1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi RM, Lupi L, Zaccone G, et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5(7):819&#x2013;824. doi: 10.1001/jamacardio.2020.1096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1096</ArticleId><ArticleId IdType="pmc">PMC7364333</ArticleId><ArticleId IdType="pubmed">32219357</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Heuvel FMA, Vos JL, Koop Y, et al. Cardiac function in relation to myocardial injury in hospitalised patients with COVID-19. Neth Heart J. 2020;28(7-8):410&#x2013;417. doi: 10.1007/s12471-020-01458-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12471-020-01458-2</ArticleId><ArticleId IdType="pmc">PMC7341471</ArticleId><ArticleId IdType="pubmed">32643071</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasudev R, Guragai N, Habib H, et al. The utility of bedside echocardiography in critically ill COVID-19 patients: Early observational findings from three Northern New Jersey hospitals. Echocardiography. 2020;37(9):1362&#x2013;1365. doi: 10.1111/echo.14825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/echo.14825</ArticleId><ArticleId IdType="pmc">PMC7436602</ArticleId><ArticleId IdType="pubmed">32789869</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Andrea A, Scarafile R, Riegler L, et al. Right Ventricular Function and Pulmonary Pressures as Independent Predictors of Survival in Patients With COVID-19 Pneumonia. JACC Cardiovasc Imaging. 2020;13(11):2467&#x2013;2468. doi: 10.1016/j.jcmg.2020.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.06.004</ArticleId><ArticleId IdType="pmc">PMC7314435</ArticleId><ArticleId IdType="pubmed">32654965</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagnesi M, Baldetti L, Beneduce A, et al. Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19. Heart. 2020;106(17):1324&#x2013;1331. doi: 10.1136/heartjnl-2020-317355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317355</ArticleId><ArticleId IdType="pmc">PMC7476272</ArticleId><ArticleId IdType="pubmed">32675217</ArticleId></ArticleIdList></Reference><Reference><Citation>Rath D, Petersen-Uribe A, Avdiu A, et al. Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection. Clin Res Cardiol. 2020;109(12):1491&#x2013;1499. doi: 10.1007/s00392-020-01683-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01683-0</ArticleId><ArticleId IdType="pmc">PMC7293880</ArticleId><ArticleId IdType="pubmed">32537662</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad MS, Shaik RA, Ahmad RK, et al. "LONG COVID": an insight. Eur Rev Med Pharmacol Sci. 2021;25(17):5561&#x2013;5577.</Citation><ArticleIdList><ArticleId IdType="pubmed">34533807</ArticleId></ArticleIdList></Reference><Reference><Citation>Visco V, Vitale C, Rispoli A, et al. Post-COVID-19 Syndrome: involvement and interactions between respiratory, cardiovascular and nervous systems. J Clin Med. 2022;11(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8836767</ArticleId><ArticleId IdType="pubmed">35159974</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YH, Zhao L, Yang XC, Wang P. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis. Rev Cardiovasc Med. 2021;22(1):159&#x2013;165. doi: 10.31083/j.rcm.2021.01.238.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.rcm.2021.01.238</ArticleId><ArticleId IdType="pubmed">33792257</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahranavard M, Akhavan Rezayat A, Zamiri Bidary M, et al. Cardiac Complications in COVID-19: A Systematic Review and Meta-analysis. Arch Iran Med. 2021;24(2):152&#x2013;163. doi: 10.34172/aim.2021.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/aim.2021.24</ArticleId><ArticleId IdType="pubmed">33636985</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Prete A, Conway F, Della Rocca DG, et al. COVID-19, Acute Myocardial Injury, and Infarction. Card Electrophysiol Clin. 2022;14(1):29&#x2013;39. doi: 10.1016/j.ccep.2021.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccep.2021.10.004</ArticleId><ArticleId IdType="pmc">PMC8556597</ArticleId><ArticleId IdType="pubmed">35221083</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802&#x2013;810. doi: 10.1001/jamacardio.2020.0950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi CM, Carubelli V, Iorio A, et al. Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. JAMA Cardiol. 2020;5(11):1274&#x2013;1280. doi: 10.1001/jamacardio.2020.3538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3538</ArticleId><ArticleId IdType="pmc">PMC7450398</ArticleId><ArticleId IdType="pubmed">32845276</ArticleId></ArticleIdList></Reference><Reference><Citation>Habets MAW, Sturkenboom HN, Tio RA, et al. How often and to what extent do admitted COVID-19 patients have signs of cardiac injury? Neth Heart J. 2021;29(Suppl 1):5&#x2013;12. doi: 10.1007/s12471-021-01571-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12471-021-01571-w</ArticleId><ArticleId IdType="pmc">PMC8050638</ArticleId><ArticleId IdType="pubmed">33860908</ArticleId></ArticleIdList></Reference><Reference><Citation>Peretto G, Sala S, Caforio ALP. Acute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement. Eur Heart J. 2020;41(22):2124&#x2013;2125. doi: 10.1093/eurheartj/ehaa396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa396</ArticleId><ArticleId IdType="pmc">PMC7197551</ArticleId><ArticleId IdType="pubmed">32363406</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto DS. COVID-19: Myocardial infarction and other coronary artery disease issues. UpToDate. 2022. https://www.uptodate.com/contents/covid-19-myocardial-infarction-and-other-coronary-artery-disease-issues. Accessed 24 Nov 2021.</Citation></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q, Hu B, Zhang Y, et al. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China. Int J Cardiol. 2020;311:116&#x2013;121. doi: 10.1016/j.ijcard.2020.03.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.03.087</ArticleId><ArticleId IdType="pmc">PMC7141178</ArticleId><ArticleId IdType="pubmed">32291207</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo A, Kasal DA, Tura BR, Lamas CC, Rey HC. Acute cardiac injury in patients with COVID-19. Am J Cardiovasc Dis. 2020;10(2):28&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7364273</ArticleId><ArticleId IdType="pubmed">32685261</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou F, Qian Z, Wang Y, Zhao Y, Bai J. Cardiac Injury and COVID-19: A Systematic Review and Meta-analysis. CJC Open. 2020;2(5):386&#x2013;394. doi: 10.1016/j.cjco.2020.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjco.2020.06.010</ArticleId><ArticleId IdType="pmc">PMC7308771</ArticleId><ArticleId IdType="pubmed">32838255</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleber R, Vilke GM, Castillo EM, et al. Trends in emergency physician opioid prescribing practices during the United States opioid crisis. Am J Emerg Med. 2020;38(4):735&#x2013;740. doi: 10.1016/j.ajem.2019.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2019.06.011</ArticleId><ArticleId IdType="pubmed">31227419</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Wang C-Y, Wang S-I, Wei JC-C. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks. eClinicalMedicine. 2022:53. 10.1016/j.eclinm.2022.101619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9366236</ArticleId><ArticleId IdType="pubmed">35971425</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nature Medicine. 2022;28,3:583&#x2013;590. 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulia EPB, Maghfirah I, Rachmi DA, Julario R. Atrial arrhythmia and its association with COVID-19 outcome: a pooled analysis. Diagnosis (Berl) 2021;8(4):532&#x2013;535. doi: 10.1515/dx-2020-0155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/dx-2020-0155</ArticleId><ArticleId IdType="pubmed">33470951</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Pan X, Li Y, et al. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review. Critical Care. 2020;24(1):468. doi: 10.1186/s13054-020-03183-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03183-z</ArticleId><ArticleId IdType="pmc">PMC7386170</ArticleId><ArticleId IdType="pubmed">32723362</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang Z, Tse G, et al. Cardiac arrhythmias in patients with COVID-19. J Arrhythm. 2020;36(5):827&#x2013;836. doi: 10.1002/joa3.12405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/joa3.12405</ArticleId><ArticleId IdType="pmc">PMC7532267</ArticleId><ArticleId IdType="pubmed">33024460</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg DD, Alviar CL, Bhatt AS, et al. Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials Network. J Card Fail. 2022;28(4):675&#x2013;681. doi: 10.1016/j.cardfail.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8762923</ArticleId><ArticleId IdType="pubmed">35051622</ArticleId></ArticleIdList></Reference><Reference><Citation>Oktaviono YH, Mulia EPB, Luke K, et al. Right ventricular dysfunction and pulmonary hypertension in COVID-19: a meta-analysis of prevalence and its association with clinical outcome. Archives of Medical Science : AMS. 2021;18,5:1169&#x2013;1180. 10.5114/aoms/136342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9479723</ArticleId><ArticleId IdType="pubmed">36160328</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong X, Yuan B, Yuan Y. Incidence and prognostic value of pulmonary embolism in COVID-19: A systematic review and meta-analysis. PLoS One. 2022;17(3):e0263580. doi: 10.1371/journal.pone.0263580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0263580</ArticleId><ArticleId IdType="pmc">PMC8920268</ArticleId><ArticleId IdType="pubmed">35286316</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M, Barco S, Giannakoulas G, et al. Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis. J Thromb Thrombolysis. 2023;55(3):490&#x2013;498. doi: 10.1007/s11239-022-02766-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-022-02766-7</ArticleId><ArticleId IdType="pmc">PMC9845812</ArticleId><ArticleId IdType="pubmed">36652137</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghantous E, Szekely Y, Lichter Y, et al. Pericardial Involvement in Patients Hospitalized With COVID-19: Prevalence, Associates, and Clinical Implications. J Am Heart Assoc. 2022;11(7):e024363. doi: 10.1161/JAHA.121.024363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.024363</ArticleId><ArticleId IdType="pmc">PMC9075494</ArticleId><ArticleId IdType="pubmed">35311354</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweck MR, Bularga A, Hahn RT, et al. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J-Cardiovasc Imaging. 2020;21(9):949&#x2013;958. doi: 10.1093/ehjci/jeaa178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa178</ArticleId><ArticleId IdType="pmc">PMC7337658</ArticleId><ArticleId IdType="pubmed">32556199</ArticleId></ArticleIdList></Reference><Reference><Citation>Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636&#x2013;2648. doi: 10.1093/eurheartj/eht210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht210</ArticleId><ArticleId IdType="pubmed">23824828</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420&#x2013;422. doi: 10.1016/S2213-2600(20)30076-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020;22(5):911&#x2013;915. doi: 10.1002/ejhf.1828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1828</ArticleId><ArticleId IdType="pmc">PMC7262276</ArticleId><ArticleId IdType="pubmed">32275347</ArticleId></ArticleIdList></Reference><Reference><Citation>Halushka MK, Vander Heide RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. 2021;50:107300. doi: 10.1016/j.carpath.2020.107300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2020.107300</ArticleId><ArticleId IdType="pmc">PMC7583586</ArticleId><ArticleId IdType="pubmed">33132119</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D, Sperhake JP, Lutgehetmann M, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020;173(4):268&#x2013;277. doi: 10.7326/M20-2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2003</ArticleId><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D, Fitzek A, Brauninger H, et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020;5(11):1281&#x2013;1285. doi: 10.1001/jamacardio.2020.3551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3551</ArticleId><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Chippa V, Aleem A, Anjum F. Post Acute Coronavirus (COVID-19) Syndrome., StatPearls [Internet]. 2022. https://www.ncbi.nlm.nih.gov/books/NBK570608/. Accessed Updated 2022 Jun 19.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval Y, Januzzi JL, Jr, Jaffe AS. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;76(10):1244&#x2013;1258. doi: 10.1016/j.jacc.2020.06.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.068</ArticleId><ArticleId IdType="pmc">PMC7833921</ArticleId><ArticleId IdType="pubmed">32652195</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman AR, Bularga A, Mills NL. High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19. Circulation. 2020;141(22):1733&#x2013;1735. doi: 10.1161/CIRCULATIONAHA.120.047008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047008</ArticleId><ArticleId IdType="pubmed">32251612</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31(5):1003&#x2013;1008. doi: 10.1111/jce.14479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.14479</ArticleId><ArticleId IdType="pmc">PMC7262150</ArticleId><ArticleId IdType="pubmed">32270559</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatla A, Mayer MM, Adusumalli S, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17(9):1439&#x2013;1444. doi: 10.1016/j.hrthm.2020.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.06.016</ArticleId><ArticleId IdType="pmc">PMC7307518</ArticleId><ArticleId IdType="pubmed">32585191</ArticleId></ArticleIdList></Reference><Reference><Citation>Si D, Du B, Ni L, et al. Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury. CMAJ. 2020;192(28):E791&#x2013;E7E8. doi: 10.1503/cmaj.200879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.200879</ArticleId><ArticleId IdType="pmc">PMC7828865</ArticleId><ArticleId IdType="pubmed">32586839</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Boursiquot BC, Melki L, Wan EY. Management of Arrhythmias Associated with COVID-19. Curr Cardiol Rep. 2020;23(1):2. doi: 10.1007/s11886-020-01434-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-020-01434-7</ArticleId><ArticleId IdType="pmc">PMC7685181</ArticleId><ArticleId IdType="pubmed">33231782</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng L, Wang S, Cai J, et al. Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis. Epidemiol Infect. 2020;148:e266. doi: 10.1017/S0950268820002587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268820002587</ArticleId><ArticleId IdType="pmc">PMC7653493</ArticleId><ArticleId IdType="pubmed">33092664</ArticleId></ArticleIdList></Reference><Reference><Citation>John KJ, Mishra AK, Ramasamy C, et al. Heart failure in COVID-19 patients: Critical care experience. World J Virol. 2022;11(1):1&#x2013;19. doi: 10.5501/wjv.v11.i1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v11.i1.1</ArticleId><ArticleId IdType="pmc">PMC8788216</ArticleId><ArticleId IdType="pubmed">35117968</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud-Elsayed HM, Moody WE, Bradlow WM, et al. Echocardiographic Findings in Patients With COVID-19 Pneumonia. Can J Cardiol. 2020;36(8):1203&#x2013;1207. doi: 10.1016/j.cjca.2020.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2020.05.030</ArticleId><ArticleId IdType="pmc">PMC7255734</ArticleId><ArticleId IdType="pubmed">32474111</ArticleId></ArticleIdList></Reference><Reference><Citation>Corica B, Marra AM, Basili S, et al. Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis. Scientific Reports. 2021;11(1):17774. doi: 10.1038/s41598-021-96955-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-96955-8</ArticleId><ArticleId IdType="pmc">PMC8423751</ArticleId><ArticleId IdType="pubmed">34493763</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li H, Zhu S, et al. Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19. JACC Cardiovasc Imaging. 2020;13(11):2287&#x2013;2299. doi: 10.1016/j.jcmg.2020.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.04.014</ArticleId><ArticleId IdType="pmc">PMC7195441</ArticleId><ArticleId IdType="pubmed">32654963</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Garcia J, Lee S, Gupta A, et al. Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19. J Am Coll Cardiol. 2020;76(20):2334&#x2013;2348. doi: 10.1016/j.jacc.2020.09.549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.09.549</ArticleId><ArticleId IdType="pmc">PMC7598769</ArticleId><ArticleId IdType="pubmed">33129663</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, Zuo Z, Yang D, et al. Venous thromboembolic events in patients with COVID-19: a systematic review and meta-analysis. Age Ageing. 2021;50(2):284&#x2013;293. doi: 10.1093/ageing/afaa259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afaa259</ArticleId><ArticleId IdType="pmc">PMC7717132</ArticleId><ArticleId IdType="pubmed">33201226</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsanos AH, Palaiodimou L, Zand R, et al. The Impact of SARS-CoV-2 on Stroke Epidemiology and Care: A Meta-Analysis. Ann Neurol. 2021;89(2):380&#x2013;388. doi: 10.1002/ana.25967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25967</ArticleId><ArticleId IdType="pmc">PMC7753413</ArticleId><ArticleId IdType="pubmed">33219563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Zhang H, He Y, et al. Association Between Ischemic Stroke and COVID-19 in China: A Population-Based Retrospective Study. Front Med (Lausanne) 2021;8:792487. doi: 10.3389/fmed.2021.792487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.792487</ArticleId><ArticleId IdType="pmc">PMC8898959</ArticleId><ArticleId IdType="pubmed">35265632</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W, Liu X, Bao K, Huang C. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol. 2022;269(4):1731&#x2013;1740. doi: 10.1007/s00415-021-10837-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10837-7</ArticleId><ArticleId IdType="pmc">PMC8517946</ArticleId><ArticleId IdType="pubmed">34652503</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Kruip M, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145&#x2013;147. doi: 10.1016/j.thromres.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Dmytriw AA, Dibas M, Schirmer CM, et al. Age and Acute Ischemic Stroke Outcome in North American Patients With COVID-19. J Am Heart Assoc. 2021;10(14):e021046. doi: 10.1161/JAHA.121.021046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.021046</ArticleId><ArticleId IdType="pmc">PMC8483479</ArticleId><ArticleId IdType="pubmed">34219466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollias A, Kyriakoulis KG, Lagou S, et al. Venous thromboembolism in COVID-19: A systematic review and meta-analysis. Vasc Med. 2021;26(4):415&#x2013;425. doi: 10.1177/1358863X21995566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1358863X21995566</ArticleId><ArticleId IdType="pmc">PMC8024143</ArticleId><ArticleId IdType="pubmed">33818197</ArticleId></ArticleIdList></Reference><Reference><Citation>Amir M, Djaharuddin I, Sudharsono A, Ramadany S. COVID-19 concomitant with infective endocarditis: A case report and review of management. Int J Infect Dis. 2020;98:109&#x2013;112. doi: 10.1016/j.ijid.2020.06.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.061</ArticleId><ArticleId IdType="pmc">PMC7305871</ArticleId><ArticleId IdType="pubmed">32574691</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R, Kumar J, Daly C, Edroos SA. Acute pericarditis as a primary presentation of COVID-19. BMJ Case Reports. 2020;13(8):e237617. doi: 10.1136/bcr-2020-237617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-237617</ArticleId><ArticleId IdType="pmc">PMC7437700</ArticleId><ArticleId IdType="pubmed">32816925</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua A, O'Gallagher K, Sado D, Byrne J. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19. Eur Heart J. 2020;41(22):2130. doi: 10.1093/eurheartj/ehaa253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa253</ArticleId><ArticleId IdType="pmc">PMC7184427</ArticleId><ArticleId IdType="pubmed">32227076</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K, Wu J, Wu F, et al. The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia. Invest Radiol. 2020;55(6):327&#x2013;331. doi: 10.1097/RLI.0000000000000672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLI.0000000000000672</ArticleId><ArticleId IdType="pmc">PMC7147273</ArticleId><ArticleId IdType="pubmed">32118615</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Arocutipa C, Saucedo-Chinchay J, Imazio M. Pericarditis in patients with COVID-19: a systematic review. J Cardiovasc Med. 2021;22(9):693&#x2013;700. doi: 10.2459/JCM.0000000000001202.</Citation><ArticleIdList><ArticleId IdType="doi">10.2459/JCM.0000000000001202</ArticleId><ArticleId IdType="pubmed">33927144</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah RM, Shah M, Shah S, Li A, Jauhar S. Takotsubo Syndrome and COVID-19: Associations and Implications. Curr Probl Cardiol. 2021;46(3):100763. doi: 10.1016/j.cpcardiol.2020.100763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100763</ArticleId><ArticleId IdType="pmc">PMC7732220</ArticleId><ArticleId IdType="pubmed">33360674</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung MK, Zidar DA, Bristow MR, et al. COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circ Res. 2021;128(8):1214&#x2013;1236. doi: 10.1161/CIRCRESAHA.121.317997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.317997</ArticleId><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Theetha Kariyanna P, Sabih A, Sutarjono B, et al. A Systematic Review of COVID-19 and Pericarditis. Cureus. 2022;14(8):e27948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9464705</ArticleId><ArticleId IdType="pubmed">36120210</ArticleId></ArticleIdList></Reference><Reference><Citation>Zvonarev V. Takotsubo Cardiomyopathy: Medical and Psychiatric Aspects. Role of Psychotropic Medications in the Treatment of Adults with "Broken Heart" Syndrome. Cureus. 2019;11(7):e5177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6695293</ArticleId><ArticleId IdType="pubmed">31423403</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabri A, Kalra A, Kumar A, et al. Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020;3(7):e2014780. doi: 10.1001/jamanetworkopen.2020.14780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.14780</ArticleId><ArticleId IdType="pmc">PMC7348683</ArticleId><ArticleId IdType="pubmed">32644140</ArticleId></ArticleIdList></Reference><Reference><Citation>Virani SS, Khan AN, Mendoza CE, Ferreira AC, de Marchena E. Takotsubo cardiomyopathy, or broken-heart syndrome. Tex Heart Inst J. 2007;34(1):76&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1847940</ArticleId><ArticleId IdType="pubmed">17420797</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorzi A, Baritussio A, ElMaghawry M, et al. Differential diagnosis at admission between Takotsubo cardiomyopathy and acute apical-anterior myocardial infarction in postmenopausal women. Eur Heart J Acute Cardiovasc Care. 2016;5(4):298&#x2013;307. doi: 10.1177/2048872615585515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048872615585515</ArticleId><ArticleId IdType="pubmed">25964511</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumo M, Akashi YJ. Role of echocardiography for takotsubo cardiomyopathy: clinical and prognostic implications. Cardiovasc Diagn Ther. 2018;8(1):90&#x2013;100. doi: 10.21037/cdt.2017.07.03.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/cdt.2017.07.03</ArticleId><ArticleId IdType="pmc">PMC5835647</ArticleId><ArticleId IdType="pubmed">29541614</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweck MR, Bularga A, Hahn RT, et al. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging. 2020;21(9):949&#x2013;958. doi: 10.1093/ehjci/jeaa178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa178</ArticleId><ArticleId IdType="pmc">PMC7337658</ArticleId><ArticleId IdType="pubmed">32556199</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino G, Croft LB, Oates CP, et al. Takotsubo Cardiomyopathy in COVID-19. J Am Coll Cardiol. 2020;76(5):628&#x2013;629. doi: 10.1016/j.jacc.2020.05.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.05.068</ArticleId><ArticleId IdType="pmc">PMC7279731</ArticleId><ArticleId IdType="pubmed">32517962</ArticleId></ArticleIdList></Reference><Reference><Citation>Citro R, Okura H, Ghadri JR, et al. Multimodality imaging in takotsubo syndrome: a joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE) J Echocardiogr. 2020;18(4):199&#x2013;224. doi: 10.1007/s12574-020-00480-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12574-020-00480-y</ArticleId><ArticleId IdType="pmc">PMC7471594</ArticleId><ArticleId IdType="pubmed">32886290</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181&#x2013;192. doi: 10.1038/s41579-018-0118-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0118-9</ArticleId><ArticleId IdType="pmc">PMC7097006</ArticleId><ArticleId IdType="pubmed">30531947</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai MM, Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res. 1997;48:1&#x2013;100. doi: 10.1016/S0065-3527(08)60286-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(08)60286-9</ArticleId><ArticleId IdType="pmc">PMC7130985</ArticleId><ArticleId IdType="pubmed">9233431</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, Park YJ, Tortorici MA, et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181(2):281&#x2013;92 e6. doi: 10.1016/j.cell.2020.02.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen JB, Hanff TC, Bress AP, South AM. Relationship Between ACE2 and Other Components of the Renin-Angiotensin System. Curr Hypertens Rep. 2020;22(7):44. doi: 10.1007/s11906-020-01048-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-020-01048-y</ArticleId><ArticleId IdType="pmc">PMC7317893</ArticleId><ArticleId IdType="pubmed">32591908</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K, Imai Y, Penninger JM. Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol. 2006;6(3):271&#x2013;276. doi: 10.1016/j.coph.2006.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2006.03.001</ArticleId><ArticleId IdType="pmc">PMC7106490</ArticleId><ArticleId IdType="pubmed">16581295</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271&#x2013;80 e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng B, Abdullahi A, Ferreira I, et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022;603,7902:706&#x2013;714. 10.1038/s41586-022-04474-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8942856</ArticleId><ArticleId IdType="pubmed">35104837</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Vanstreels E, Jansen S, Daelemans D. Cellular host factors for SARS-CoV-2 infection. Nat Microbiol. 2021;6(10):1219&#x2013;1232. doi: 10.1038/s41564-021-00958-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00958-0</ArticleId><ArticleId IdType="pubmed">34471255</ArticleId></ArticleIdList></Reference><Reference><Citation>Snijder EJ, van der Meer Y, Zevenhoven-Dobbe J, et al. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol. 2006;80(12):5927&#x2013;5940. doi: 10.1128/JVI.02501-05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02501-05</ArticleId><ArticleId IdType="pmc">PMC1472606</ArticleId><ArticleId IdType="pubmed">16731931</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu HY, Brian DA. Subgenomic messenger RNA amplification in coronaviruses. Proc Natl Acad Sci U S A. 2010;107(27):12257&#x2013;12262. doi: 10.1073/pnas.1000378107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1000378107</ArticleId><ArticleId IdType="pmc">PMC2901459</ArticleId><ArticleId IdType="pubmed">20562343</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia HP, Look DC, Shi L, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79(23):14614&#x2013;14621. doi: 10.1128/JVI.79.23.14614-14621.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.23.14614-14621.2005</ArticleId><ArticleId IdType="pmc">PMC1287568</ArticleId><ArticleId IdType="pubmed">16282461</ArticleId></ArticleIdList></Reference><Reference><Citation>Crackower MA, Sarao R, Oudit GY, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417(6891):822&#x2013;828. doi: 10.1038/nature00786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature00786</ArticleId><ArticleId IdType="pubmed">12075344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Vabret N, Britton GJ, Gruber C, et al. Immunology of COVID-19: Current State of the Science. Immunity. 2020;52(6):910&#x2013;941. doi: 10.1016/j.immuni.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7200337</ArticleId><ArticleId IdType="pubmed">32505227</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463&#x2013;1471. doi: 10.1016/j.hrthm.2020.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7199677</ArticleId><ArticleId IdType="pubmed">32387246</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustine JN, Jones D. Immunopathology of Hyperinflammation in COVID-19. Am J Pathol. 2021;191(1):4&#x2013;17. doi: 10.1016/j.ajpath.2020.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2020.08.009</ArticleId><ArticleId IdType="pmc">PMC7484812</ArticleId><ArticleId IdType="pubmed">32919977</ArticleId></ArticleIdList></Reference><Reference><Citation>Italia L, Tomasoni D, Bisegna S, et al. COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae. Front Cardiovasc Med. 2021;8:713560. doi: 10.3389/fcvm.2021.713560.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.713560</ArticleId><ArticleId IdType="pmc">PMC8382715</ArticleId><ArticleId IdType="pubmed">34447795</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeghate EA, Eid N, Singh J. Mechanisms of COVID-19-induced heart failure: a short review. Heart Fail Rev. 2021;26(2):363&#x2013;369. doi: 10.1007/s10741-020-10037-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-020-10037-x</ArticleId><ArticleId IdType="pmc">PMC7666972</ArticleId><ArticleId IdType="pubmed">33191474</ArticleId></ArticleIdList></Reference><Reference><Citation>Deswal A, Petersen NJ, Feldman AM, et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST) Circulation. 2001;103(16):2055&#x2013;2059. doi: 10.1161/01.CIR.103.16.2055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.103.16.2055</ArticleId><ArticleId IdType="pubmed">11319194</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tassell BW, Raleigh JM, Abbate A. Targeting interleukin-1 in heart failure and inflammatory heart disease. Curr Heart Fail Rep. 2015;12(1):33&#x2013;41. doi: 10.1007/s11897-014-0231-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11897-014-0231-7</ArticleId><ArticleId IdType="pubmed">25315037</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tassell BW, Toldo S, Mezzaroma E, Abbate A. Targeting interleukin-1 in heart disease. Circulation. 2013;128(17):1910&#x2013;1923. doi: 10.1161/CIRCULATIONAHA.113.003199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.003199</ArticleId><ArticleId IdType="pmc">PMC3938092</ArticleId><ArticleId IdType="pubmed">24146121</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatsumi T, Matoba S, Kawahara A, et al. Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes. J Am Coll Cardiol. 2000;35(5):1338&#x2013;1346. doi: 10.1016/S0735-1097(00)00526-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(00)00526-X</ArticleId><ArticleId IdType="pubmed">10758978</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley LF, Abbate A. Interleukin-1 blockade in cardiovascular diseases: a clinical update. Eur Heart J. 2018;39(22):2063&#x2013;2069. doi: 10.1093/eurheartj/ehy128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy128</ArticleId><ArticleId IdType="pubmed">29584915</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner SJ, Libby P. Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J Immunol. 1989;142(1):100&#x2013;109. doi: 10.4049/jimmunol.142.1.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.142.1.100</ArticleId><ArticleId IdType="pubmed">2783319</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmugam G, Narasimhan M, Sakthivel R, et al. A biphasic effect of TNF-alpha in regulation of the Keap1/Nrf2 pathway in cardiomyocytes. Redox Biol. 2016;9:77&#x2013;89. doi: 10.1016/j.redox.2016.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2016.06.004</ArticleId><ArticleId IdType="pmc">PMC4961303</ArticleId><ArticleId IdType="pubmed">27423013</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumertl T, Lokau J, Rose-John S, Garbers C. Function and proteolytic generation of the soluble interleukin-6 receptor in health and disease. Biochim Biophys Acta Mol Cell Res. 2022;1869(1):119143. doi: 10.1016/j.bbamcr.2021.119143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2021.119143</ArticleId><ArticleId IdType="pubmed">34626681</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting Interleukin-6 Signaling in Clinic. Immunity. 2019;50(4):1007&#x2013;1023. doi: 10.1016/j.immuni.2019.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.03.026</ArticleId><ArticleId IdType="pubmed">30995492</ArticleId></ArticleIdList></Reference><Reference><Citation>Su JH, Luo MY, Liang N, et al. Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases. Front Pharmacol. 2021;12:745061. doi: 10.3389/fphar.2021.745061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.745061</ArticleId><ArticleId IdType="pmc">PMC8421530</ArticleId><ArticleId IdType="pubmed">34504432</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol. 2019;19(1):63&#x2013;64. doi: 10.1038/s41577-018-0098-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0098-z</ArticleId><ArticleId IdType="pubmed">30552387</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL. Inflammatory cytokines and cardiac arrhythmias: the lesson from COVID-19. Nat Rev Immunol. 2022;22(5):270&#x2013;272. doi: 10.1038/s41577-022-00714-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00714-3</ArticleId><ArticleId IdType="pmc">PMC8959266</ArticleId><ArticleId IdType="pubmed">35347295</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H, Liu J, Ding J, et al. Arrhythmias in patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: Incidences and implications. J Electrocardiol. 2021;65:96&#x2013;101. doi: 10.1016/j.jelectrocard.2021.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2021.01.012</ArticleId><ArticleId IdType="pmc">PMC7830267</ArticleId><ArticleId IdType="pubmed">33588259</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin GA, Desai AD, Chai Z, et al. Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic. JAMA Netw Open. 2021;4(4):e216842. doi: 10.1001/jamanetworkopen.2021.6842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.6842</ArticleId><ArticleId IdType="pmc">PMC8065381</ArticleId><ArticleId IdType="pubmed">33890991</ArticleId></ArticleIdList></Reference><Reference><Citation>Musikantow DR, Turagam MK, Sartori S, et al. Atrial Fibrillation in Patients Hospitalized With COVID-19: Incidence, Predictors, Outcomes, and Comparison to Influenza. JACC Clin Electrophysiol. 2021;7(9):1120&#x2013;1130. doi: 10.1016/j.jacep.2021.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2021.02.009</ArticleId><ArticleId IdType="pmc">PMC7904279</ArticleId><ArticleId IdType="pubmed">33895107</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu PP, Blet A, Smyth D, Li H. The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation. 2020;142(1):68&#x2013;78. doi: 10.1161/CIRCULATIONAHA.120.047549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047549</ArticleId><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubbi S, Nazari MA, Taieb D, Klubo-Gwiezdzinska J, Pacak K. Catecholamine physiology and its implications in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8(12):978&#x2013;986. doi: 10.1016/S2213-8587(20)30342-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30342-9</ArticleId><ArticleId IdType="pmc">PMC7598304</ArticleId><ArticleId IdType="pubmed">33128872</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal AK, Garg R, Ritch A, Sarkar P. Postural orthostatic tachycardia syndrome. Postgrad Med J. 2007;83(981):478&#x2013;480. doi: 10.1136/pgmj.2006.055046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.2006.055046</ArticleId><ArticleId IdType="pmc">PMC2600095</ArticleId><ArticleId IdType="pubmed">17621618</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau ST, Yu WC, Mok NS, et al. Tachycardia amongst subjects recovering from severe acute respiratory syndrome (SARS) Int J Cardiol. 2005;100(1):167&#x2013;169. doi: 10.1016/j.ijcard.2004.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2004.06.022</ArticleId><ArticleId IdType="pmc">PMC7132412</ArticleId><ArticleId IdType="pubmed">15820302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14(3):247&#x2013;250. doi: 10.1016/j.dsx.2020.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.03.013</ArticleId><ArticleId IdType="pmc">PMC7102662</ArticleId><ArticleId IdType="pubmed">32247212</ArticleId></ArticleIdList></Reference><Reference><Citation>Triposkiadis F, Xanthopoulos A, Butler J. Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;74(6):804&#x2013;813. doi: 10.1016/j.jacc.2019.06.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.06.053</ArticleId><ArticleId IdType="pubmed">31395131</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Lucio J, Peinado VI, de Jover L, et al. Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease. PLoS One. 2018;13(4):e0195724. doi: 10.1371/journal.pone.0195724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0195724</ArticleId><ArticleId IdType="pmc">PMC5908268</ArticleId><ArticleId IdType="pubmed">29672621</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo A, Escobar S, Tibirica E. Systemic endothelial dysfunction: A common pathway for COVID-19, cardiovascular and metabolic diseases. Nutr Metab Cardiovasc Dis. 2020;30(8):1401&#x2013;1402. doi: 10.1016/j.numecd.2020.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7233254</ArticleId><ArticleId IdType="pubmed">32425360</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017;149:38&#x2013;44. doi: 10.1016/j.thromres.2016.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2016.11.007</ArticleId><ArticleId IdType="pubmed">27886531</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, Luscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41(32):3038&#x2013;3044. doi: 10.1093/eurheartj/ehaa623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta N, Zhao YY, Evans CE. The stimulation of thrombosis by hypoxia. Thromb Res. 2019;181:77&#x2013;83. doi: 10.1016/j.thromres.2019.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2019.07.013</ArticleId><ArticleId IdType="pubmed">31376606</ArticleId></ArticleIdList></Reference><Reference><Citation>Farshidfar F, Koleini N, Ardehali H. Cardiovascular complications of COVID-19. JCI Insight. 2021;6. 10.1172/jci.insight.148980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8410051</ArticleId><ArticleId IdType="pubmed">34061779</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Zhou L, Sun X, et al. Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. Sci Rep. 2017;7(1):9110. doi: 10.1038/s41598-017-09536-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09536-z</ArticleId><ArticleId IdType="pmc">PMC5567209</ArticleId><ArticleId IdType="pubmed">28831119</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: How to define it and how to manage it. BMJ. 2020;370:m3489. doi: 10.1136/bmj.m3489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Long COVID or Post-COVID Conditions. In: COVID-19 National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases, Centers for Disease Control and Prevention. 2022. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html. Accessed 1 Sept 2022.</Citation></Reference><Reference><Citation>Drake TM, Riad AM, Fairfield CJ, et al. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet. 2021;398(10296):223&#x2013;237. doi: 10.1016/S0140-6736(21)00799-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00799-6</ArticleId><ArticleId IdType="pmc">PMC8285118</ArticleId><ArticleId IdType="pubmed">34274064</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41(19):1821&#x2013;1829. doi: 10.1093/eurheartj/ehaa388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa388</ArticleId><ArticleId IdType="pmc">PMC7239204</ArticleId><ArticleId IdType="pubmed">32383763</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846&#x2013;848. doi: 10.1007/s00134-020-05991-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal P, Choi JJ, Pinheiro LC, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372&#x2013;2374. doi: 10.1056/NEJMc2010419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2010419</ArticleId><ArticleId IdType="pmc">PMC7182018</ArticleId><ArticleId IdType="pubmed">32302078</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Torres-Macho J, Velasco-Arribas M, et al. Preexisting hypertension is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: a case&#x2013;control study. J Human Hypertens. 2022;36(6):582&#x2013;584. doi: 10.1038/s41371-022-00660-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-022-00660-6</ArticleId><ArticleId IdType="pmc">PMC8853057</ArticleId><ArticleId IdType="pubmed">35173268</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Misra A. Post COVID-19 Syndrome ("Long COVID") and Diabetes: Challenges in Diagnosis and Management. Diabetes Metab Syndr. 2021;15(5):102235. doi: 10.1016/j.dsx.2021.102235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.102235</ArticleId><ArticleId IdType="pmc">PMC8317446</ArticleId><ArticleId IdType="pubmed">34384972</ArticleId></ArticleIdList></Reference><Reference><Citation>Soler MJ, Barrios C, Oliva R, Batlle D. Pharmacologic modulation of ACE2 expression. Curr Hypertens Rep. 2008;10(5):410&#x2013;414. doi: 10.1007/s11906-008-0076-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-008-0076-0</ArticleId><ArticleId IdType="pmc">PMC7089438</ArticleId><ArticleId IdType="pubmed">18775121</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhakaran D, Perel P, Roy A, et al. Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings. Glob Heart. 2020;15(1):44. doi: 10.5334/gh.823.</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/gh.823</ArticleId><ArticleId IdType="pmc">PMC7413193</ArticleId><ArticleId IdType="pubmed">32923338</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta N, Kalra A, Nowacki AS, et al. Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5(9):1020&#x2013;1026. doi: 10.1001/jamacardio.2020.1855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1855</ArticleId><ArticleId IdType="pmc">PMC7201375</ArticleId><ArticleId IdType="pubmed">32936273</ArticleId></ArticleIdList></Reference><Reference><Citation>de Abajo FJ, Rodr&#xed;guez-Mart&#xed;n S, Lerma V, et al. Use of renin&#x2013;angiotensin&#x2013;aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet. 2020;395(10238):1705&#x2013;1714. doi: 10.1016/S0140-6736(20)31030-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31030-8</ArticleId><ArticleId IdType="pmc">PMC7255214</ArticleId><ArticleId IdType="pubmed">32416785</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. N Engl J Med. 2020;382(25):2431&#x2013;2440. doi: 10.1056/NEJMoa2006923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2006923</ArticleId><ArticleId IdType="pmc">PMC7206933</ArticleId><ArticleId IdType="pubmed">32356627</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Ruiz I. RAAS inhibitors do not increase the risk of COVID-19. Nat Rev Cardiol. 2020;17(7):383. doi: 10.1038/s41569-020-0401-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0401-0</ArticleId><ArticleId IdType="pmc">PMC7243952</ArticleId><ArticleId IdType="pubmed">32444693</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeli F, Verdecchia P, Reboldi G. RAAS Inhibitors and Risk of Covid-19. N Engl J Med. 2020;383(20):1990&#x2013;1991. doi: 10.1056/NEJMc2030446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2030446</ArticleId><ArticleId IdType="pubmed">33108102</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarcho JA, Ingelfinger JR, Hamel MB, D'Agostino RB, Sr, Harrington DP. Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19. N Engl J Med. 2020;382(25):2462&#x2013;2464. doi: 10.1056/NEJMe2012924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2012924</ArticleId><ArticleId IdType="pmc">PMC7224604</ArticleId><ArticleId IdType="pubmed">32356625</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B, Kovacs R, Harrington B. Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. J Card Fail. 2020;26(5):370. doi: 10.1016/j.cardfail.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7234783</ArticleId><ArticleId IdType="pubmed">32439095</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes RD, Macedo AVS, de Barros ESPGM, et al. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. JAMA. 2021;325(3):254&#x2013;264. doi: 10.1001/jama.2020.25864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.25864</ArticleId><ArticleId IdType="pmc">PMC7816106</ArticleId><ArticleId IdType="pubmed">33464336</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey JR, Caro-Codon J, Rosillo SO, et al. Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications. Eur J Heart Fail. 2020;22(12):2205&#x2013;2215. doi: 10.1002/ejhf.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1990</ArticleId><ArticleId IdType="pmc">PMC7461427</ArticleId><ArticleId IdType="pubmed">32833283</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiology ACo. HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. Am College Cardiol. 2020. https://www.acc.org/latest-in-cardiology/articles/2020/03/17/08/59/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19. Accessed 17 Mar 2020.</Citation></Reference><Reference><Citation>Cardiology ESo. Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers. European Society of Cardiology. 2020. https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang (2020). Accessed 13 Mar 2020.</Citation></Reference><Reference><Citation>Vaduganathan M, Vardeny O, Michel T, et al. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020;382(17):1653&#x2013;1659. doi: 10.1056/NEJMsr2005760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr2005760</ArticleId><ArticleId IdType="pmc">PMC7121452</ArticleId><ArticleId IdType="pubmed">32227760</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Black BK, Biaggioni I, et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation. 2009;120(9):725&#x2013;734. doi: 10.1161/CIRCULATIONAHA.108.846501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.846501</ArticleId><ArticleId IdType="pmc">PMC2758650</ArticleId><ArticleId IdType="pubmed">19687359</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzieh M, Moroi MK, Aboujamous NM, et al. Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo. Am J Cardiol. 2019;124(12):1889&#x2013;1893. doi: 10.1016/j.amjcard.2019.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2019.09.008</ArticleId><ArticleId IdType="pubmed">31653351</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinitz JS, Goyal R, Harding M, et al. Bradyarrhythmias in patients with COVID-19: Marker of poor prognosis? Pacing Clin Electrophysiol. 2020;43(10):1199&#x2013;1204. doi: 10.1111/pace.14042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.14042</ArticleId><ArticleId IdType="pmc">PMC7461386</ArticleId><ArticleId IdType="pubmed">32820823</ArticleId></ArticleIdList></Reference><Reference><Citation>Azarkish M, Laleh Far V, Eslami M, Mollazadeh R. Transient complete heart block in a patient with critical COVID-19. Eur Heart J. 2020;41(22):2131. doi: 10.1093/eurheartj/ehaa307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa307</ArticleId><ArticleId IdType="pmc">PMC7184360</ArticleId><ArticleId IdType="pubmed">32285920</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhtar Z, Leung LW, Kontogiannis C, et al. Prevalence of bradyarrhythmias needing pacing in COVID-19. Pacing Clin Electrophysiol. 2021;44(8):1340&#x2013;1346. doi: 10.1111/pace.14313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.14313</ArticleId><ArticleId IdType="pmc">PMC8447422</ArticleId><ArticleId IdType="pubmed">34240439</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Assaf O, Mirza M, Musa A. Atypical presentation of COVID-19 as subclinical myocarditis with persistent high-degree atrioventricular block treated with pacemaker implant. HeartRhythm Case Rep. 2020;6(11):884&#x2013;887. doi: 10.1016/j.hrcr.2020.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrcr.2020.09.003</ArticleId><ArticleId IdType="pmc">PMC7490251</ArticleId><ArticleId IdType="pubmed">32953452</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta MD, Qamar A, Mp G, et al. Bradyarrhythmias in patients with COVID-19: A case series. Indian Pacing Electrophysiol J. 2020;20(5):211&#x2013;212. doi: 10.1016/j.ipej.2020.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ipej.2020.08.004</ArticleId><ArticleId IdType="pmc">PMC7434619</ArticleId><ArticleId IdType="pubmed">32822746</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M, Brucato A, Barbieri A, et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation. 2013;128(1):42&#x2013;49. doi: 10.1161/CIRCULATIONAHA.113.001531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.001531</ArticleId><ArticleId IdType="pubmed">23709669</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J. 2015;36(42):2921&#x2013;2964. doi: 10.1093/eurheartj/ehv318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv318</ArticleId><ArticleId IdType="pmc">PMC7539677</ArticleId><ArticleId IdType="pubmed">26320112</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M, Brucato A, Cemin R, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369(16):1522&#x2013;1528. doi: 10.1056/NEJMoa1208536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1208536</ArticleId><ArticleId IdType="pubmed">23992557</ArticleId></ArticleIdList></Reference><Reference><Citation>Imazio M, Brucato A, Trinchero R, Spodick D, Adler Y. Individualized therapy for pericarditis. Expert Rev Cardiovasc Ther. 2009;7(8):965&#x2013;975. doi: 10.1586/erc.09.82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erc.09.82</ArticleId><ArticleId IdType="pubmed">19673674</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramacciotti E, Barile Agati L, Calderaro D, et al. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial. Lancet. 2022;399(10319):50&#x2013;59. doi: 10.1016/S0140-6736(21)02392-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02392-8</ArticleId><ArticleId IdType="pmc">PMC8673881</ArticleId><ArticleId IdType="pubmed">34921756</ArticleId></ArticleIdList></Reference><Reference><Citation>Giossi R, Menichelli D, Pani A, et al. A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients. Front Pharmacol. 2021;12:698008. doi: 10.3389/fphar.2021.698008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.698008</ArticleId><ArticleId IdType="pmc">PMC8443784</ArticleId><ArticleId IdType="pubmed">34539396</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes GD, Burnett A, Allen A, et al. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020;50(1):72&#x2013;81. doi: 10.1007/s11239-020-02138-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02138-z</ArticleId><ArticleId IdType="pmc">PMC7241581</ArticleId><ArticleId IdType="pubmed">32440883</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkoudah E, Piazza G, Hecht TEH, et al. Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative. Am J Med. 2020;133(Suppl 1):1&#x2013;27. doi: 10.1016/j.amjmed.2019.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2019.12.001</ArticleId><ArticleId IdType="pubmed">32362349</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Barratt SL, Condliffe R, et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75(11):1009&#x2013;1016. doi: 10.1136/thoraxjnl-2020-215314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215314</ArticleId><ArticleId IdType="pubmed">32839287</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2362&#x2013;2371. doi: 10.1016/j.jacc.2015.09.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.09.035</ArticleId><ArticleId IdType="pubmed">26542657</ArticleId></ArticleIdList></Reference><Reference><Citation>Yek C, Warner S, Wiltz JL, et al. Risk Factors for Severe COVID-19 Outcomes Among Persons Aged &gt;/=18 Years Who Completed a Primary COVID-19 Vaccination Series - 465 Health Care Facilities, United States, December 2020-October 2021. MMWR Morb Mortal Wkly Rep. 2022;71(1):19&#x2013;25. doi: 10.15585/mmwr.mm7101a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7101a4</ArticleId><ArticleId IdType="pmc">PMC8735560</ArticleId><ArticleId IdType="pubmed">34990440</ArticleId></ArticleIdList></Reference><Reference><Citation>Team. UHSAC-E. The effectiveness of vaccination against long covid: a rapid evidence briefing. 2022. https://www.icpcovid.com/sites/default/files/2022-02/Ep241-9UKHealthSecurityAgencyTheeffectivenessofvaccinationagainstlongCOVIDFeb2022.pdf. Accessed 25 Nov 2022.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>